PDCD1 and neoplasm: The combination of Tcm and anti-PD-1 delayed the development of i.d. B16-OVA tumour (Fig. 6d) and s.c. MC38-OVA tumour (Fig. 6e) when compared to the treatment with Tcm cells alone.